A Retrospective Study of Pediatric Patients With Low- or Intermediate-Risk Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation for the AML-05 Study Conducted by the Japanese Pediatric Leukemia/Lymphoma Study Group
Yoshiko Hashii(The University of Osaka), Koji Kato, Michihiro Yano(Akita University), Nobuyuki Hyakuna(University of the Ryukyus), Kimikazu Matsumoto(National Center For Child Health and Development), Masayuki Nagasawa(Tokyo Medical and Dental University), Yozo Nakazawa(Tokyo University of Agriculture), Daisuke Tomizawa(National Center For Child Health and Development), Takashi Taga(Erasmus MC), Hiroyuki Fujisaki(Osaka City General Hospital), Katsuyoshi Koh(Saitama Children's Medical Center), Nao Yoshida(Nihon University), Harumi Kakuda(Chiba Hospital), Hiromasa Yabe(Tokai University), Souichi Adachi(Kyoto University), Hiroyuki Ishida(Kyoto City Hospital), Masakatsu Yanagimachi(Kanagawa Children's Medical Center), Katsutsugu Umeda(Kyoto University), Daiichiro Hasegawa(Kobe Children's Hospital), Koji Kawaguchi(Shizuoka Children's Hospital), Ken Tabuchi, Tomohiko Taki(Kyorin University), Hiroyuki Kurakami(Osaka University Hospital), Yoshiyuki Takahashi(Nagoya University), Atsushi Satou(Miyagi Children's Hospital)
Cited by 1
Related Papers
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383
Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
|International Journal of Hematology|2007|345